ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2025

Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).

Nargiz Majidova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.